BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND ATP1A1, P05023, MGC51750, MGC3285, ENSG00000163399, 476 AND Treatment
32 results:

  • 1. Tumor-Informed Circulating Tumor DNA for Minimal Residual Disease Detection in the Management of colorectal cancer.
    Emiloju OE; Storandt M; Zemla T; Tran N; Jethwa K; Mahipal A; Mitchell J; Thiels C; Mathis K; McWilliams R; Hubbard J; Sinicrope F; Shi Q; Jin Z
    JCO Precis Oncol; 2024 Jan; 8():e2300127. PubMed ID: 38237099
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. COLD SNARE POLYPECTOMY: A SAFE PROCEDURE FOR REMOVING SMALL NON-PEDUNCULATED colorectal LESIONS.
    Santos CEOD; Malaman D; Sanmartin IDA; Leão ABS; Bombassaro IZ; Pereira-Lima JC
    Arq Gastroenterol; 2023; 60(4):470-477. PubMed ID: 38018552
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Secondary Primary cancer Risk After Radiation Therapy in Rectal cancer: A Population-Based Cohort Study With Propensity Score Matching.
    Schlesinger-Raab A; Schubert-Fritschle G; Kim M; Werner J; Belka C; Wolff H; Agha A; Fuchs M; Friess H; Combs S; Häussler B; Engel J; Halfter K
    Clin Colorectal Cancer; 2023 Dec; 22(4):485-495.e3. PubMed ID: 37838522
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Development of a prognostic model for personalized prediction of colon adenocarcinoma (COAD) patient outcomes using methylation-driven genes.
    Chen D; Zhang B; Kang K; Li L; Liao Y; Qing S; Di Y
    J Appl Genet; 2023 Dec; 64(4):713-721. PubMed ID: 37589877
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Time Interval Between the End of Neoadjuvant Therapy and Elective Resection of Locally Advanced Rectal cancer in the CRONOS Study.
    Guzmán Y; Ríos J; Paredes J; Domínguez P; Maurel J; González-Abós C; Otero-Piñeiro A; Almenara R; Ladra M; Prada B; Pascual M; Guerrero MA; García-Granero Á; Fernández L; Ochogavia-Seguí A; Gamundi-Cuesta M; González-Argente FX; Pons LV; Centeno A; Arrayás Á; de Miguel A; Gil-Gómez E; Gómez B; Martínez JG; Lacy AM; de Lacy FB
    JAMA Surg; 2023 Sep; 158(9):910-919. PubMed ID: 37436726
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. treatment and Survival Outcomes for Patients with colorectal Peritoneal Metastases Deemed Ineligible for Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Results of a Retrospective Study.
    Dietz MV; Ziekman MJ; van Kooten JP; Brandt-Kerkhof ARM; van Meerten E; Verhoef C; Madsen EVE
    Ann Surg Oncol; 2023 Apr; 30(4):2048-2056. PubMed ID: 36566258
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. cancer diagnostic tools to aid decision-making in primary care: mixed-methods systematic reviews and cost-effectiveness analysis.
    Medina-Lara A; Grigore B; Lewis R; Peters J; Price S; Landa P; Robinson S; Neal R; Hamilton W; Spencer AE
    Health Technol Assess; 2020 Nov; 24(66):1-332. PubMed ID: 33252328
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genetic Predictors of Severe Skin Toxicity in Patients with Stage III Colon cancer Treated with Cetuximab: NCCTG N0147 (Alliance).
    Labadie JD; Hua X; Harrison TA; Banbury BL; Huyghe JR; Sun W; Shi Q; Yothers G; Alberts SR; Sinicrope FA; Goldberg RM; George TJ; Penney KL; Phipps AI; Cohen SA; Peters U; Chan AT; Newcomb PA
    Cancer Epidemiol Biomarkers Prev; 2021 Feb; 30(2):404-411. PubMed ID: 33203692
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The Influence of Systemic Inflammation on treatment Response and Survival in Anal Squamous Cell cancer.
    Knight K; Choong JX; McKee RF; Anderson JH; Horgan PG; McMillan DC; McDonald A; Roxburgh CS
    Clin Oncol (R Coll Radiol); 2021 Jan; 33(1):e22-e30. PubMed ID: 32709540
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Multicentre study of perioperative
    Allard MA; Nishioka Y; Beghdadi N; Imai K; Gelli M; Yamashita S; Kitano Y; Kokudo T; Yamashita YI; Sa Cunha A; Vibert E; Elias D; Cherqui D; Goere D; Adam R; Baba H; Hasegawa K
    BJS Open; 2019 Oct; 3(5):678-686. PubMed ID: 31592094
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Improved high-quality colon cleansing with 1L NER1006 versus 2L polyethylene glycol + ascorbate or oral sulfate solution.
    Repici A; Coron E; Sharma P; Spada C; Di Leo M; Noble CL; Gschossmann J; Bargalló García A; Baumgart DC
    Dig Liver Dis; 2019 Dec; 51(12):1671-1677. PubMed ID: 31409579
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Systematic review of endoluminal vacuum-assisted therapy as salvage treatment for rectal anastomotic leakage.
    Shalaby M; Emile S; Elfeki H; Sakr A; Wexner SD; Sileri P
    BJS Open; 2019 Apr; 3(2):153-160. PubMed ID: 30957061
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. New insights into niclosamide action: autophagy activation in colorectal cancer.
    Newton PT
    Biochem J; 2019 Mar; 476(5):779-781. PubMed ID: 30842311
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Survival after a cancer diagnosis among solid organ transplant recipients in the United States.
    D'Arcy ME; Coghill AE; Lynch CF; Koch LA; Li J; Pawlish KS; Morris CR; Rao C; Engels EA
    Cancer; 2019 Mar; 125(6):933-942. PubMed ID: 30624768
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Incidence of cardiovascular disease up to 13 year after cancer diagnosis: A matched cohort study among 32 757 cancer survivors.
    Schoormans D; Vissers PAJ; van Herk-Sukel MPP; Denollet J; Pedersen SS; Dalton SO; Rottmann N; van de Poll-Franse L
    Cancer Med; 2018 Oct; 7(10):4952-4963. PubMed ID: 30220107
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Measuring colorectal cancer incidence: the performance of an algorithm using administrative health data.
    Diop M; Strumpf EC; Datta GD
    BMC Med Res Methodol; 2018 May; 18(1):38. PubMed ID: 29739338
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Surrogate Endpoints in Second-Line Trials of Targeted Agents in Metastatic colorectal cancer: A Literature-Based Systematic Review and Meta-Analysis.
    Cremolini C; Antoniotti C; Pietrantonio F; Berenato R; Tampellini M; Baratelli C; Salvatore L; Marmorino F; Borelli B; Nichetti F; Bironzo P; Sonetto C; Bartolomeo MD; Braud F; Loupakis F; Falcone A; Di Maio M
    Cancer Res Treat; 2017 Jul; 49(3):834-845. PubMed ID: 27857020
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Young patients with synchronous colorectal liver metastases.
    Smith JD; Lowery MA; Fell D; Gallagher DJ; Nash GM; Kemeny NE
    J Surg Oncol; 2016 Apr; 113(5):473-6. PubMed ID: 27110700
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. SNPs in transporter and metabolizing genes as predictive markers for oxaliplatin treatment in colorectal cancer patients.
    Kap EJ; Seibold P; Scherer D; Habermann N; Balavarca Y; Jansen L; Zucknick M; Becker N; Hoffmeister M; Ulrich A; Benner A; Ulrich CM; Burwinkel B; Brenner H; Chang-Claude J
    Int J Cancer; 2016 Jun; 138(12):2993-3001. PubMed ID: 26835885
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Further evidence for preoperative chemoradiotherapy and transanal endoscopic surgery (TEM) in T2-3s,N0,M0 rectal cancer.
    Pericay C; Serra-Aracil X; Ocaña-Rojas J; Mora-López L; Dotor E; Casalots A; Pisa A; Saigí E
    Clin Transl Oncol; 2016 Jul; 18(7):666-71. PubMed ID: 26497352
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.